HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 23498835, compound → 5-Ethanesulfonyl-3-[1-(3-{3-[4-(2-hydroxyacetyl)-piperazin-1-yl]-propyl}-4,5,6,7-tetrahydro-1h-indol-2-yl)-meth-(z)-ylidene]-1,3-dihydro-indol-2-one
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 23498835 | HCID 23498835 | — |
| Reactant | HCID 23498854 | HCID 23498854 | — |
| Product | 5-Ethanesulfonyl-3-[1-(3-{3-[4-(2-hydroxyacetyl)-piperazin-1-yl]-propyl}-4,5,6,7-tetrahydro-1h-indol-2-yl)-meth-(z)-ylidene]-1,3-dihydro-indol-2-one | HCID 44299233 | 28.4% |
Reaction Steps
3-{3-[4-(2-Hydroxy-acetyl)-piperazin-1-yl]-propyl}-4,5,6,7-tetrahydro-1H-indole-2-carbaldehyde (134 mg, 0.3 mmol), prepared as described in Example 13, was condensed with 5-ethylsulfonyloxindole (102 mg, 72% pure) following the procedure used in Example 1. Dark solid was precipitated out and purified by flash chromatography, eluting with (dichloromethane/methanol 10/1) to give 46 mg of the desired product.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06777417B2 |
| Source dataset | uspto-grants-2004_08 |
| ORD ID | ord-1d04c1479ec0410783b5272d099b13cb |
| Source note | uspto-grants-2004_08 |